Synthesis and biological activities of topopyrones.

Structure-activity studies were employed to investigate the stabilization of DNA-topoisomerases I and II covalent binary complexes by topopyrone analogues. The synthesis of five new topopyrone derivatives and study of their ability to stabilize DNA-topoisomerase I and DNA-topoisomerase II covalent binary complexes are described. The biochemical assays suggest that the orientation of the fused 1,4-pyrone ring and halogen substituents contribute importantly to the overall potency of the topopyrones as topoisomerase poisons.

[1]  Jun Lu,et al.  Calothrixins, a new class of human DNA topoisomerase I poisons. , 2009, Journal of natural products.

[2]  Q. Khan,et al.  The topopyrones poison human DNA topoisomerases I and II. , 2008, Journal of the American Chemical Society.

[3]  S. Hecht,et al.  Total synthesis of the topopyrones: a new class of topoisomerase I poisons. , 2008, The Journal of organic chemistry.

[4]  L. Tietze,et al.  Synthesis of Highly Functionalized Anthraquinones and Evaluation of Their Antitumor Activity , 2007 .

[5]  Y. Pommier,et al.  Synthesis and mechanism of action studies of a series of norindenoisoquinoline topoisomerase I poisons reveal an inhibitor with a flipped orientation in the ternary DNA-enzyme-inhibitor complex as determined by X-ray crystallographic analysis. , 2005, Journal of medicinal chemistry.

[6]  Y. Pommier,et al.  Structures of three classes of anticancer agents bound to the human topoisomerase I-DNA covalent complex. , 2005, Journal of medicinal chemistry.

[7]  K. Kohn,et al.  Differential induction of topoisomerase I-DNA cleavage complexes by the indenoisoquinoline MJ-III-65 (NSC 706744) and camptothecin: base sequence analysis and activity against camptothecin-resistant topoisomerases I. , 2003, Cancer research.

[8]  S. Hecht,et al.  Solid-phase synthesis of bleomycin group antibiotics. Construction of a 108-member deglycobleomycin library. , 2003, Journal of the American Chemical Society.

[9]  Lance Stewart,et al.  The mechanism of topoisomerase I poisoning by a camptothecin analog , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[10]  JAMES C. Wang,et al.  Cellular roles of DNA topoisomerases: a molecular perspective , 2002, Nature Reviews Molecular Cell Biology.

[11]  V. I. Rozenberg,et al.  Regioselective Fries Rearrangement and Friedel−Crafts Acylation as Efficient Routes to Novel Enantiomerically Enriched ortho‐Acylhydroxy[2.2]paracyclophanes , 2000 .

[12]  H. Takahashi,et al.  Novel human topoisomerase I inhibitors, topopyrones A, B, C and D. I. Producing strain, fermentation, isolation, physico-chemical properties and biological activity. , 2000, The Journal of antibiotics.

[13]  D. Ishiyama,et al.  Novel human topoisomerase I inhibitors, topopyrones A, B, C and D. II. Structure elucidation. , 2000, The Journal of antibiotics.

[14]  U. Flörke,et al.  Biomimetic-type synthesis of benzo[a]naphthacenequinones related to pradimicinone. , 2000, The Journal of organic chemistry.

[15]  S. Hecht,et al.  Total Synthesis of Bleomycin Group Antibiotics. Total Syntheses of Bleomycin Demethyl A2, Bleomycin A2, and Decarbamoyl Bleomycin Demethyl A2 , 1998 .

[16]  G. Hofmann,et al.  Biochemical and pharmacological properties of p170 and p180 forms of topoisomerase II. , 1989, Biochemistry.

[17]  R. Hertzberg,et al.  On the mechanism of topoisomerase I inhibition by camptothecin: evidence for binding to an enzyme-DNA complex. , 1989, Biochemistry.

[18]  O. Westergaard,et al.  A high affinity topoisomerase I binding sequence is clustered at DNAase I hypersensitive sites in tetrahymena R-chromatin , 1985, Cell.

[19]  L. Liu,et al.  Nonintercalative antitumor drugs interfere with the breakage-reunion reaction of mammalian DNA topoisomerase II. , 1984, The Journal of biological chemistry.

[20]  J. Wang,et al.  Covalent bonds between protein and DNA. Formation of phosphotyrosine linkage between certain DNA topoisomerases and DNA. , 1980, The Journal of biological chemistry.

[21]  J. Champoux.  DNA topoisomerases: structure, function, and mechanism. , 2001, Annual review of biochemistry.

[22]  L. Liu,et al.  DNA topoisomerase poisons as antitumor drugs. , 1989, Annual review of biochemistry.

[23]  Jacques Savard,et al.  Reactions of ketene acetals-14 The use of simple mixed vinylketene acetals in the annulation of quinones , 1984 .

[24]  W. Gilbert,et al.  Sequencing end-labeled DNA with base-specific chemical cleavages. , 1980, Methods in enzymology.

[25]  K. Venkataraman,et al.  387. Synthetical experiments in the chromone group. Part XIV. The action of sodamide on 1-acyloxy-2-acetonaphthones , 1934 .

[26]  W. Baker.  322. Molecular rearrangement of some o-acyloxyacetophenones and the mechanism of the production of 3-acylchromones , 1933 .